Rhode Island House Bill H7716

Rhode Island 2026 Regular Session

• Introduced: 2/12/26
• Refer: 2/12/26
• Report Pass: 4/2/26
• Engrossed: 4/9/26
• Refer: 4/14/26

Caption

RELATING TO FOOD AND DRUGS -- THE RHODE ISLAND CANNABIS ACT

Summary

H7716 amends the Rhode Island Cannabis Act’s definitions section. The bill specifically revises the definition of “cannabinoid profile” by removing the existing requirement that cannabinoid amounts be expressed as dry-weight percentages. Under the bill, the Cannabis Control Commission would continue to determine the form and manner for reporting cannabinoid profile information, and it may still regulate amounts of other cannabinoids. The measure is narrow and technical, focused on how cannabis products are described, tested, labeled, or regulated under state law rather than changing who may buy, sell, or cultivate cannabis. It leaves the broader structure of the adult-use and medical cannabis regulatory framework intact, but gives the commission more flexibility in setting standards for cannabinoid reporting and product compliance.

Impact

The bill updates a definition in chapter 21-28.11 of the General Laws, which governs Rhode Island’s cannabis regulatory system. Its main legal effect is to remove statutory language requiring cannabinoid profile values to be stated as dry-weight percentages, thereby allowing the Cannabis Control Commission to establish another reporting format by rule or regulation. This could affect testing laboratories, manufacturers, cultivators, retailers, and regulators involved in product labeling, compliance testing, and product recalls, but it does not otherwise alter licensing categories or cannabis possession rules.

Sentiment

The available voting history shows strong support and no recorded opposition. The House Committee on Corporations approved the bill 14-0, and the full House passed it 63-0. With no committee transcript available, there is no evidence of significant public or legislative controversy in the materials provided. The unanimous votes suggest the bill was viewed as a routine technical update to cannabis regulation.

Contention

No notable contention appears in the provided record. Because the bill is limited to a definitional change, any discussion would likely center on technical compliance issues, laboratory reporting standards, and whether the commission should have flexibility to set cannabinoid measurement requirements. However, the vote totals and absence of recorded debate indicate that no member or stakeholder opposition is reflected in the available materials.